Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis. - Kubesch, Alica; Lande, Raul; Leutgöb, Anna; Farrag, Karima; Dahmer, Iulia; Stratmann-Vollrath, Katharina; Dienethal, Antje; Michael, Florian Alexander; Sprinzl, Kathrin; Zeuzem, Stefan; Blumenstein, Irina (PLoS ONE, 2025)